A Multicenter Clinical Study of the Sonablate®450 for the TreAtment of Locally Recurrent Prostate Cancer With HIFU (STAR Trial)

NCT00772317 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 117

Last updated 2019-04-10

No results posted yet for this study

Summary

For the treatment of locally recurrent prostate cancer following failed external beam radiation therapy (EBRT)

Conditions

  • Recurrent Prostate Cancer

Interventions

DEVICE

High Intensity Focused Ultrasound

High Intensity Focused Ultrasound

Sponsors & Collaborators

  • SonaCare Medical

    lead INDUSTRY

Principal Investigators

  • Mark Carol, MD · SonaCare Medical, LLC

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
40 Years
Max Age
85 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-07-31
Primary Completion
2020-12-31
Completion
2021-12-31

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00772317 on ClinicalTrials.gov